Skip to main content

Project: Evo

By Dave Muoio | 08:50 pm | February 24, 2020
The large, multi-site investigation described clear improvement in objective symptoms of pediatric attention deficit, but was a bit muddier when describing subjective measures and long-term efficacy.
By Dave Muoio | 03:00 pm | January 15, 2020
Topline data released today by the digital therapeutics company also suggest that its FDA approval-pending treatment continued to deliver benefits with continued use.
By Dave Muoio | 04:38 pm | March 07, 2019
Of note, the deal specifies that Akili will still control the rollout and support of its video game-like therapy through a yet-to-be-seen digital distribution platform.
By Dave Muoio | 01:05 pm | January 09, 2019
At CES 2019, the digital therapeutic company's CEO and cofounder described work on an independent prescription, procurement and support platform specific to digital medicines.
By Dave Muoio | 04:51 pm | January 03, 2019
The study's 19 young participants stuck to their regimens, and along with their parents said that they would be open to continuing treatment sessions. 
By Dave Muoio | 10:59 am | August 09, 2018
Boston-based digital therapeutics company Akili Interactive Labs announced this morning that it has added an extra $13 million to its previously announced Series C financing.
By Dave Muoio | 11:05 am | May 09, 2018
This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round.